Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR

International Journal of Cancer

Volumn 103, Issue 1, 2003, Pages 126-131

  Weber, Theresia ^a   Lacroix, Jeannine ^a   Wörner, Stefan ^a   Weckauf, Helgard ^a   Winkler, Steffi ^a   Hinz, Ulf ^a   Schilling, Tobias ^a   Frank Raue, Karin ^b   Klar, Ernst ^a   Von Knebel Doeberitz, Magnus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Endokrinologische Gemeinschaftspraxis   (Germany)

Author keywords

Disseminated tumor cells; Lymph node metastases; Thyroid carcinoma

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 20; PEPTIDE HORMONE; PREPROGASTRIN RELEASING PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW; BONE MARROW METASTASIS; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; BONE MARROW; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; PEPTIDES; PROTEIN PRECURSORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037211651     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10804     Document Type: Article

References (40)

1. Sherman SI, Brierly JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Tayler T, Maxon III HR. Prospective multicenter study of thyroid carcinoma treatment. Initial analysis of staging and outcome. Cancer 1998;83:1012-21.
2. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Hölzer S. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 2000;89:202-17.
3. Hölzer S, Reiners C, Mann K, Bamberg M, Rothmund M, Dudeck J, Stewart AK, Hundahl SA. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. Cancer 2000;89:192-201.
4. Donis-Keller H, Dou S, Chi S, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2:851-6.
5. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnaclife A, Ponder BAJ. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-60.
6. Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess A, Cote GJ, Gagel RF, Evans DB. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 1990;5:697-707.
7. Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 2000;88:1909-15.
8. Kebebew E, Ituarte PHG, Siperstein AE, Duh Q-Y, Clark OH. Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139-48.
9. Weber T, Schilling T, Frank-Raue K, Colombo-Benkmann M, Hinz U, Ziegler R, Klar E. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinoma. Surgery 2001;130:1044-9.
10. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986;99:60-6.
11. Moley JF, Dilley WG, DeBenedetti MK. Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 1997;225:734-43.
12. Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma. Ann Surg 1999;229:880-8.
13. Ghossein RA, Bhattacharya S, Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 1999;5:1950-60.
14. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999;91:1113-24.
15. Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111:567-80.
16. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. Am J Pathol 1992;140:427-47.
17. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-81.
18. Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B, Kalthoff H. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997;57:3106-10.
19. Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C, von Knebel Doeberitz M. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 1998;4:343-8.
20. Wildi S, Kleeff J, Maruyama H, Maurer CA, Friess H, Büchler MW, Lander AD, Korc, M. Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer. Clin Cancer Res 1999;5:2840-7.
21. Klein A, Zemer R, Buchumensky V, Klaper V, Nissenkorn I. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer 1998;82:349-54.
22. Klein A, Fishman A, Zemer R, Zimlichman S, Altaras MM. Detection of tumor circulating cells by cytokeratin 20 in the blood of patients with endometrial carcinoma. Gynecol Oncol 2000;78:352-5.
23. Fishman A, Klein A, Zemer R, Zimlichman S, Bernheim J, Cohen I, Altaras MM. Detection of micrometastasis by cytokeratin 20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. Gynecol Oncol 2000;77:399-404.
24. Weber T, Lacroix J, Weitz J, Amann K, Magener A, Hölting T, Klar E, Herfarth C, von Knebel Doeberitz, M. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction. Br J Cancer 2000;82:157-60.
25. Weber T, Amann K, Weckauf H, Lacroix J, Weitz J, Klar E, Herfarth C, von Knebel Doeberitz, M. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 RT-PCR. World J Surg 2002;26:148-52.
26. 2+ and stimulation of calcitonin secretion from human medullary thyroid carcinoma cells by the gastrin-releasing peptide. Biochem Biophys Res Com 1992;185:833-8.
27. Kameya T, Bressho T, Tsumuraya M, Yamaguchi K, Abe K, Shimosato Y, Yanaihara N. Production of gastrin-releasing peptide by medullary carcinoma of the thyroid. Virchows Arch 1983;401:99-108.
28. Bostwick DG, Bensch KG. Gastrin releasing peptide in human neuroendocrine tumors. J Pathol 1985;147:237-44.
29. Price J, Nieuwenhuijzen Kruseman C, Doniach I, Howlett TA, Besser GM, Rees LH. Bombesin-like peptides in human endocrine tumors: Quantitation, biochemical characterization, and secretion. J Clin Endocrinol Metab 1985;60:1097-103.
30. Modigliani E, Casanova S, Chayvialle JA, Bernard C, Franc B, Cohen R, Calmettes C. Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:831-5.
31. Sunday ME, Wolfe HJ, Roos BA, Chin WW, Spindel ER. Gastrin-releasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroid C-cells. Endocrinology 1988;122:1551-8.
32. Inaji H, Komoike Y, Motomura K, Higashiyama M, Ohtsuru M, Funai H, Kasugai T, Koyama H. Demonstration and diagnostic significance for pro-gastrin-releasing peptide in medullary thyroid carcinoma. Oncology 2000;59:122-5.
33. McKillop JM, McCann JP, Gibbons JR, Johnston CF, Buchanan KD. Gastrin-releasing peptide in normal and neoplastic human lung: Measurement and biochemical characterization. Int J Cancer 1990;46:591-6.
34. Lacroix J, Becker HD, Woerner SM, Rittgen W, Drings P, von Knebel Doeberitz M. Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR. Int J Cancer 2001;92:1-8.
35. Hsu EM, McNicol PJ, Guijon FB, Paraskevas M. Quantification of HPV-16E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. Int J Cancer 1993;55:397-401.
36. Weitz J, Kienle P, Magener A, Koch M, Schrödel A, Willeke F, Autschbach F, Lacroix J, Lehnert T, Herfarth C, von Knebel Doeberitz M. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999;5:1830-6.
37. Futamura M, Takagi Y, Koumura H, Kida H, Tanemura H, Shimokawa K, Saji S. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 1998;68:34-40.
38. Rosenberg R, Hoos A, Mueller J, Nekarda H. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer 2000;83:1323-9.
39. Wyld DK, Selby P, Perren TJ, Jonas SK, Allen-Mersh TG, Wheeldon J, Burchill SA. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998;79:288-93.
40. Yamamoto N, Kato Y, Yanagisawa A, Ohta H, Takahashi T, Kitagawa T. Predictive value of genetic diagnosis for cancer micrometastasis. Cancer 1997;80:1393-8.